These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 15621736

  • 21. Successful treatment with the monoclonal antibody rituximab in two children with refractory autoimmune thrombocytopenia.
    Pusiol A, Cesaro S, Nocerino A, Picco G, Zanesco L, Bisogno G.
    Eur J Pediatr; 2004 Jun; 163(6):305-7. PubMed ID: 15346911
    [Abstract] [Full Text] [Related]

  • 22. Rituximab for the treatment of acute refractory ITP.
    Kim SG, Whyte D, Pashankar FD.
    J Pediatr Hematol Oncol; 2014 Apr; 36(3):e149-51. PubMed ID: 23669737
    [Abstract] [Full Text] [Related]

  • 23. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
    Shanafelt TD, Madueme HL, Wolf RC, Tefferi A.
    Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
    [Abstract] [Full Text] [Related]

  • 24. Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment.
    Parodi E, Nobili B, Perrotta S, Rosaria Matarese SM, Russo G, Licciardello M, Zecca M, Locatelli F, Cesaro S, Bisogno G, Giordano P, De Mattia D, Ramenghia U.
    Int J Hematol; 2006 Jul; 84(1):48-53. PubMed ID: 16867902
    [Abstract] [Full Text] [Related]

  • 25. Very long-term remission induced by short-term rituximab monotherapy in a patient with heavily pretreated, chronic immune thrombocytopenic purpura.
    Clausen MR, Segel E, Brandsborg M, d'Amore F.
    Eur J Haematol; 2011 Mar; 86(3):256-9. PubMed ID: 21166717
    [Abstract] [Full Text] [Related]

  • 26. [Rituximab treatment of chronic idiopathic thrombocytopenic purpura. Results of a phase II study].
    Meo P, Stipa E, La Presa M, Bianchi M, Di Giulio C, Stasi R, Amadori S.
    Recenti Prog Med; 2002 Mar; 93(7-8):421-7. PubMed ID: 12138687
    [Abstract] [Full Text] [Related]

  • 27. One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab.
    Mueller BU, Bennett CM, Feldman HA, Bussel JB, Abshire TC, Moore TB, Sawaf H, Loh ML, Rogers ZR, Glader BE, McCarthy MC, Mahoney DH, Olson TA, Feig SA, Lorenzana AN, Mentzer WC, Buchanan GR, Neufeld EJ, Pediatric Rituximab/ITP Study Group, Glaser Pediatric Research Network.
    Pediatr Blood Cancer; 2009 Feb; 52(2):259-62. PubMed ID: 18937333
    [Abstract] [Full Text] [Related]

  • 28. A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia.
    Saleh MN, Gutheil J, Moore M, Bunch PW, Butler J, Kunkel L, Grillo-López AJ, LoBuglio AF.
    Semin Oncol; 2000 Dec; 27(6 Suppl 12):99-103. PubMed ID: 11226008
    [Abstract] [Full Text] [Related]

  • 29. Low-dose rituximab in adult patients with primary immune thrombocytopenia.
    Zaja F, Vianelli N, Volpetti S, Battista ML, Defina M, Palmieri S, Bocchia M, Medeot M, De Luca S, Ferrara F, Isola M, Baccarani M, Fanin R.
    Eur J Haematol; 2010 Oct; 85(4):329-34. PubMed ID: 20546023
    [Abstract] [Full Text] [Related]

  • 30. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.
    Godeau B, Porcher R, Fain O, Lefrère F, Fenaux P, Cheze S, Vekhoff A, Chauveheid MP, Stirnemann J, Galicier L, Bourgeois E, Haiat S, Varet B, Leporrier M, Papo T, Khellaf M, Michel M, Bierling P.
    Blood; 2008 Aug 15; 112(4):999-1004. PubMed ID: 18463354
    [Abstract] [Full Text] [Related]

  • 31. Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura in a patient with Kabuki syndrome.
    Torii Y, Yagasaki H, Tanaka H, Mizuno S, Nishio N, Muramatsu H, Hama A, Takahashi Y, Kojima S.
    Int J Hematol; 2009 Sep 15; 90(2):174-176. PubMed ID: 19662467
    [Abstract] [Full Text] [Related]

  • 32. The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura.
    Pasa S, Altintas A, Cil T, Danis R, Ayyildiz O.
    J Thromb Thrombolysis; 2009 Apr 15; 27(3):329-33. PubMed ID: 18311541
    [Abstract] [Full Text] [Related]

  • 33. Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura.
    Zaja F, Battista ML, Pirrotta MT, Palmieri S, Montagna M, Vianelli N, Marin L, Cavallin M, Bocchia M, Defina M, Ippoliti M, Ferrara F, Patriarca F, Avanzini MA, Regazzi M, Baccarani M, Isola M, Soldano F, Fanin R.
    Haematologica; 2008 Jun 15; 93(6):930-3. PubMed ID: 18403395
    [Abstract] [Full Text] [Related]

  • 34. Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura.
    Delgado J, Bustos JG, Jimenez-Yuste V, Hernandez-Navarro F.
    Haematologica; 2002 Feb 15; 87(2):215-6. PubMed ID: 11836172
    [Abstract] [Full Text] [Related]

  • 35. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
    Gómez-Almaguer D.
    Hematology; 2012 Apr 15; 17 Suppl 1():S25-7. PubMed ID: 22507772
    [Abstract] [Full Text] [Related]

  • 36. Rituximab treatment for chronic refractory idiopathic thrombocytopenic purpura.
    Zhou Z, Yang R.
    Crit Rev Oncol Hematol; 2008 Jan 15; 65(1):21-31. PubMed ID: 17681784
    [Abstract] [Full Text] [Related]

  • 37. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
    Zhang C, Liu HF, Chen XH, Gao L, Gao L, Liu Y, Kong PY, Sun AH, Zhang X.
    Clin Ther; 2014 Mar 01; 36(3):385-8. PubMed ID: 24594069
    [Abstract] [Full Text] [Related]

  • 38. [Idiopathic thrombocytopenic purpura associated with mantle cell lymphoma showing an increase in the platelet count receiving anti-CD20 antibody rituximab].
    Kawachi Y, Ide M, Uchida T, Setsu K.
    Rinsho Ketsueki; 2003 Jan 01; 44(1):31-3. PubMed ID: 12649836
    [Abstract] [Full Text] [Related]

  • 39. Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases.
    Hindilerden F, Yönal-Hindilerden İ, Yenerel MN, Nalçacı M, Diz-Küçükkaya R.
    Turk J Haematol; 2017 Mar 01; 34(1):72-80. PubMed ID: 27102929
    [Abstract] [Full Text] [Related]

  • 40. Clinical remission following monoclonal anti-CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura.
    Moschovi M, Trimis G, Pergantou H, Platokouki H, Vrachnou E, Tzortzatou-Stathopoulou F.
    J Paediatr Child Health; 2005 Jul 01; 41(7):384-6. PubMed ID: 16014149
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.